ATE122567T1 - Insulinzubereitungen, die nikotinsäure oder nikotinamid enthalten. - Google Patents

Insulinzubereitungen, die nikotinsäure oder nikotinamid enthalten.

Info

Publication number
ATE122567T1
ATE122567T1 AT91901711T AT91901711T ATE122567T1 AT E122567 T1 ATE122567 T1 AT E122567T1 AT 91901711 T AT91901711 T AT 91901711T AT 91901711 T AT91901711 T AT 91901711T AT E122567 T1 ATE122567 T1 AT E122567T1
Authority
AT
Austria
Prior art keywords
nicotinic acid
nicotinamide
preparations containing
insulin preparations
pct
Prior art date
Application number
AT91901711T
Other languages
English (en)
Inventor
Klavs Holger Jorgensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK654389A external-priority patent/DK654389D0/da
Priority claimed from DK7190A external-priority patent/DK7190D0/da
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE122567T1 publication Critical patent/ATE122567T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
AT91901711T 1989-12-21 1990-12-20 Insulinzubereitungen, die nikotinsäure oder nikotinamid enthalten. ATE122567T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK654389A DK654389D0 (da) 1989-12-21 1989-12-21 Laegemiddel
DK7190A DK7190D0 (da) 1990-01-10 1990-01-10 Laegemiddel

Publications (1)

Publication Number Publication Date
ATE122567T1 true ATE122567T1 (de) 1995-06-15

Family

ID=26063239

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91901711T ATE122567T1 (de) 1989-12-21 1990-12-20 Insulinzubereitungen, die nikotinsäure oder nikotinamid enthalten.

Country Status (10)

Country Link
US (1) US5382574A (de)
EP (1) EP0506792B1 (de)
JP (1) JP3122128B2 (de)
AT (1) ATE122567T1 (de)
AU (1) AU641721B2 (de)
CA (1) CA2070814A1 (de)
DE (1) DE69019534T2 (de)
DK (1) DK0506792T3 (de)
ES (1) ES2072596T3 (de)
WO (1) WO1991009617A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3562195A (en) * 1994-10-04 1996-04-26 Novo Nordisk A/S Preparations containing aspb28 human insulin and nicotinamide
US5830999A (en) * 1995-01-26 1998-11-03 Regents Of The University Of California Stabilization of insulin through ligand binding interations
EP0880969A1 (de) 1997-05-28 1998-12-02 Applied Research Systems ARS Holdings N.V. Im physiologischem Medium schwerlösliche pharmazeutische Peptidezusammensetzungen
CN1317967A (zh) * 1998-09-17 2001-10-17 伊莱利利公司 蛋白质制剂
US6573237B2 (en) 2001-03-16 2003-06-03 Eli Lilly And Company Protein formulations
EP1660531A2 (de) 2003-08-05 2006-05-31 Novo Nordisk A/S Neue insulinderivate
US9737511B2 (en) * 2004-05-24 2017-08-22 Geoffrey C. GURTNER Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux
US8829051B2 (en) * 2004-05-24 2014-09-09 Geoffrey C. GURTNER Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux
DK1969004T3 (da) * 2005-12-28 2011-11-28 Novo Nordisk As Insulinsammensætninger og metode til at lave en sammensætning
US9034818B2 (en) 2007-06-13 2015-05-19 Novo Nordisk A/S Pharmaceutical formulations comprising an insulin derivative
US10098857B2 (en) 2008-10-10 2018-10-16 The Board Of Trustees Of The Leland Stanford Junior University Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds
CA2738615A1 (en) * 2008-10-30 2010-05-06 Novo Nordisk A/S Treating diabetes melitus using insulin injections with less than daily injection frequency
FR2943538B1 (fr) 2009-03-27 2011-05-20 Adocia Formulation a action rapide d'insuline recombinante humaine
US9018190B2 (en) 2009-03-27 2015-04-28 Adocia Functionalized oligosaccharides
AU2013203134B2 (en) * 2009-06-26 2016-05-12 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and an amino acid
CN102470165B (zh) 2009-06-26 2014-12-24 诺沃-诺迪斯克有限公司 包含胰岛素、烟酰胺和氨基酸的制剂
BR112013010345A2 (pt) 2010-10-27 2017-07-25 Novo Nordisk As tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção
WO2012080320A1 (en) 2010-12-14 2012-06-21 Novo Nordisk A/S Fast-acting insulin in combination with long-acting insulin
AU2011343360A1 (en) 2010-12-14 2013-06-06 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and an amino acid
US20130231281A1 (en) 2011-11-02 2013-09-05 Adocia Rapid acting insulin formulation comprising an oligosaccharide
WO2013130943A1 (en) * 2012-03-02 2013-09-06 Genentech, Inc. Alkyl-and di-substituted amido-benzyl sulfonamide derivatives
WO2013130935A1 (en) * 2012-03-02 2013-09-06 Genentech, Inc. Amido-benzyl sulfoxide derivatives
EP2873422A4 (de) 2012-07-10 2015-12-30 Takeda Pharmaceutical Pharmazeutische zubereitung zur injektion
ES2670969T3 (es) 2012-11-13 2018-06-04 Adocia Formulación de acción rápida de insulina que comprende un compuesto aniónico sustituido
US10137172B2 (en) 2013-04-30 2018-11-27 Novo Nordisk A/S Administration regime
WO2015120457A1 (en) * 2014-02-10 2015-08-13 Biodel Inc. Stabilized ultra-rapid-acting insulin formulations
AR099569A1 (es) * 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
US20170028031A1 (en) * 2014-03-07 2017-02-02 Klavs Holger Jørgensen Novel fast acting insulin preparations
FR3020947B1 (fr) 2014-05-14 2018-08-31 Adocia Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
EP3341401A1 (de) * 2015-08-25 2018-07-04 Novo Nordisk A/S Neuartige insulinderivate und medizinische verwendungen davon
AU2016311283B2 (en) * 2015-08-25 2020-10-08 Novo Nordisk A/S Novel insulin derivatives and the medical uses hereof
FR3043557B1 (fr) 2015-11-16 2019-05-31 Adocia Composition a action rapide d'insuline comprenant un citrate substitue
GB201607918D0 (en) 2016-05-06 2016-06-22 Arecor Ltd Novel formulations
EP3518893A1 (de) 2016-09-29 2019-08-07 Arecor Limited Neuartige formulierungen
GB201707189D0 (en) 2017-05-05 2017-06-21 Arecor Ltd Novel formulations
GB201707188D0 (en) 2017-05-05 2017-06-21 Arecor Ltd Novel formulations
GB201707187D0 (en) 2017-05-05 2017-06-21 Arecor Ltd Novel formulations
WO2019055490A1 (en) 2017-09-14 2019-03-21 The Board Of Trustees Of The Leland Stanford Junior University PACKAGING OF IRRADIED FABRIC FOR FAT GREETING RETENTION
CN112004521A (zh) 2018-04-04 2020-11-27 艾瑞克有限公司 用于递送胰岛素化合物的医用输注泵系统
IL277721B2 (en) 2018-04-04 2024-03-01 Arecor Ltd Medical infusion pump for administering an insulin compound
CN112040928A (zh) 2018-04-04 2020-12-04 艾瑞克有限公司 用于递送胰岛素化合物的医用输注泵系统
TWI829687B (zh) * 2018-05-07 2024-01-21 丹麥商諾佛 儂迪克股份有限公司 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物
FR3083985A1 (fr) 2018-07-23 2020-01-24 Adocia Dispositif pour injecter une solution d'insuline(s)
WO2019243627A1 (fr) 2018-06-23 2019-12-26 Adocia Dispositif pour injecter une solution d'insuline(s)
FR3083984A1 (fr) 2018-07-23 2020-01-24 Adocia Dispositif pour injecter une solution d'insuline(s)
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
EP4073097A1 (de) 2019-12-11 2022-10-19 Novo Nordisk A/S Neuartige insulinanaloga und verwendungen davon
GB202004814D0 (en) 2020-04-01 2020-05-13 Arecor Ltd Novel formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2179384A (en) * 1937-04-05 1939-11-07 Univ Alberta Therapeutic composition and process of making it
US2538018A (en) * 1944-04-04 1951-01-16 Nordisk Insulinlab Crystalline product of insulin and alkaline protein and process of making it
US2793977A (en) * 1951-08-31 1957-05-28 Caspe Saul Compositions and method for reducing blood sugar concentration
DK116527B (da) * 1967-03-01 1970-01-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af en hurtigtvirkende, holdbar, neutral opløsning af rent krystallinsk okseinsulin eller okseinsulin, der ved tilsætning af Zn er krystalliserbart i vand, eller blandinger af okseinsulin og insulin af anden oprindelse.
GB1603639A (en) * 1978-05-26 1981-11-25 Haggar H Composition for application to the hair and scalp
US5155096A (en) * 1987-06-15 1992-10-13 Garcia Y Bellon Donato P Method for potentiation of a therapeutic agent
CA1299102C (en) * 1987-06-15 1992-04-21 Steven G. Ayre Insulin potentiation therapy
DE3850568D1 (de) * 1987-10-08 1994-08-11 Andor Bilas Stoffgemisch zur stabilisierung der stoffwechsel-lage.

Also Published As

Publication number Publication date
AU641721B2 (en) 1993-09-30
DK0506792T3 (da) 1995-10-09
EP0506792A1 (de) 1992-10-07
JP3122128B2 (ja) 2001-01-09
DE69019534D1 (de) 1995-06-22
CA2070814A1 (en) 1991-06-22
ES2072596T3 (es) 1995-07-16
EP0506792B1 (de) 1995-05-17
AU7047191A (en) 1991-07-24
US5382574A (en) 1995-01-17
DE69019534T2 (de) 1995-09-21
WO1991009617A1 (en) 1991-07-11
JPH05502234A (ja) 1993-04-22

Similar Documents

Publication Publication Date Title
DE69019534D1 (de) Insulinzubereitungen, die nikotinsäure oder nikotinamid enthalten.
ZA907338B (en) Thienylcarboxylates of amino alcohols
HUT71900A (en) Injection and injection kit containing omeprazole and its analogs
DK0473333T3 (da) Modificeret polydextrose og fremgangsmåde til fremstilling heraf
AU580355B2 (en) N-((4,6-dimethoxypyrimidin-2-YL)Aminocarbonyl)-3- trifluoromethylpridine-2-sulfonamide or salts thereof, herbicidal composition containing the same, and process for the production of the compound
TR27525A (tr) Propenoik asit türevleri, hazirlanmalarina mahsus usuller ve fungisid olarak kullanimlari.
NO880558L (no) Pyridin-2,4- og 2,5-dikarboksylsyreamid, samt fremgangsmaate for fremstilling derav.
ATE71771T1 (de) Kupferoxid-supraleiter mit gemischter wertigkeit und verfahren zu seiner herstellung.
NL191790C (nl) 4,5-Trimethyleen-4-isothiazolin-3-onen, werkwijze ter bereiding daarvan alsmede toepassing daarvan als bactericiden en fungiciden.
ATE158793T1 (de) Neue salzform von 5-difluormethoxy-2- (3,4- dimethoxy-2-pyridyl)methylsulfinyl>-1h- benzimidazol
EP0224842A3 (en) Pyrazolesulfonamide derivative, process for its production and herbicide containing it
PT91132A (pt) Processo para a preparacao de hidrohaletos de rifapentina
DK0482108T3 (da) Substituerede 2-imidazoliner samt fremstilling og anvendelse deraf
ATE107129T1 (de) Zusammensetzungen, die 2- thiocyanomethylthiobenzothiazol enthalten.
GB1446584A (en) Agent for deodorising and influencing perspiration
EP0390181A3 (de) Perylenquinon (UCN-1028D)-Derivate
DK621688A (da) Ethylerede avermectiner og praeparater indeholdende disse til behandling og forhindring af parasitinfektioner hos mennesker og dyr
ES548791A0 (es) Un procedimiento para preparar una sal de metal alcalino o alcalino-terreo de 5-cianopiridin-2-diazohidroxido
ES8707706A1 (es) Un procedimiento para la preparacion de nuevos derivados de propanodiona.
AR242792A1 (es) Compuestos de sulfonamida y sales de los mismos, composiciones herbicidas que los contienen y procedimiento para producirlos.
DE69013403T2 (de) Polypeptid mit thrombin-inhibierender Wirkung und Verfahren zu dessen Herstellung.
PT90281A (pt) Processo para a preparacao de composicoes insecticidas contendo 1-dimetilcarbamoil-1h-1,2,4,triazois substituidos nas posicoes 3 e 5
CS9100077A2 (en) 2,13-d-disubstituted ergolines and method of their production
MY102682A (en) Substituted pyridinesulfonamide compounds, herbicidal composition containing them, and method of preparing these compounds
HUT56348A (en) Process for producing pyridine-2,4- and 2,5-dicarboxylic acid diamides and pharmaceutical compositions comprising such compounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee